|
Volumn 768, Issue 2, 2002, Pages 341-348
|
Quantification of methyldopa in human plasma by high-performance liquid chromatography-electrospray tandem mass spectrometry: Application to a bioequivalence study
|
Author keywords
Bioequivalence studies; Methyldopa
|
Indexed keywords
CHROMATOGRAPHIC ANALYSIS;
LIQUID CHROMATOGRAPHY;
CHROMATOGRAPHIC RUN TIME;
CHROMATOGRAPHY;
BENZENE DERIVATIVE;
DOPA PHENYL D3;
LEGRAND METILDOPA;
METHYLDOPA;
UNCLASSIFIED DRUG;
ACCURACY;
ADULT;
ANALYTIC METHOD;
AREA UNDER THE CURVE;
ARTICLE;
BIOEQUIVALENCE;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG DETERMINATION;
DRUG FORMULATION;
FEMALE;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
HUMAN EXPERIMENT;
MALE;
NORMAL HUMAN;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
TABLET FORMULATION;
TANDEM MASS SPECTROMETRY;
CALIBRATION;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
HUMANS;
METHYLDOPA;
REPRODUCIBILITY OF RESULTS;
SENSITIVITY AND SPECIFICITY;
SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;
THERAPEUTIC EQUIVALENCY;
|
EID: 0037022766
PISSN: 15700232
EISSN: None
Source Type: Journal
DOI: 10.1016/S1570-0232(01)00612-2 Document Type: Article |
Times cited : (27)
|
References (8)
|